CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: pantoprazole
Accession: CHEBI:7915
browse the term
Definition: A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Synonyms: exact_synonym: 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
related_synonym: Formula=C16H15F2N3O4S; InChI=1S/C16H15F2N3O4S/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16/h3-7,15H,8H2,1-2H3,(H,20,21); InChIKey=IQPSEEYGBUAQFF-UHFFFAOYSA-N; SMILES=COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC; pantoprazol; pantoprazolum
xref: CAS:102625-70-7; DrugBank:DB00213; Drug_Central:2054; HMDB:HMDB0005017; KEGG:C11806; KEGG:D05353; LINCS:LSM-1390
xref_mesh: MESH:C064276
xref: PMID:11110229; PMID:11240974; Patent:EP166287; Patent:US4758579; Reaxys:5361474; VSDB:2958; Wikipedia:Pantoprazole
cyclic_relationship: is_conjugate_acid_of CHEBI:50358
G
Abca1
ATP binding cassette subfamily A member 1
increases expression
ISO
pantoprazole results in increased expression of ABCA1 mRNA
CTD
PMID:20060385
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
pantoprazole promotes the reaction [ABCC2 protein affects the transport of estradiol-17 beta-glucuronide]
CTD
PMID:12702717
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
pantoprazole inhibits the reaction [ABCG2 protein affects the transport of 7-hydroxymethotrexate]
CTD
PMID:17032904
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
C1qa
complement C1q A chain
decreases expression
EXP
pantoprazole results in decreased expression of C1QA mRNA
CTD
PMID:25626140
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
G
C1qc
complement C1q C chain
decreases expression
EXP
pantoprazole results in decreased expression of C1QC mRNA
CTD
PMID:25626140
NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:149,127,415...149,131,017
G
C4bpa
complement component 4 binding protein, alpha
decreases expression
EXP
pantoprazole results in decreased expression of C4BPA mRNA
CTD
PMID:25626140
NCBI chr13:42,075,715...42,111,205
Ensembl chr13:42,075,717...42,111,205
G
C4bpb
complement component 4 binding protein, beta
decreases expression
EXP
pantoprazole results in decreased expression of C4BPB mRNA
CTD
PMID:25626140
NCBI chr13:42,120,798...42,131,515
Ensembl chr13:42,120,798...42,131,817
G
Casp3
caspase 3
multiple interactions
EXP
pantoprazole inhibits the reaction [Indomethacin results in increased activity of CASP3 protein]
CTD
PMID:18853145
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cfi
complement factor I
decreases expression
EXP
pantoprazole results in decreased expression of CFI mRNA
CTD
PMID:25626140
NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:218,387,990...218,430,561
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression decreases expression
EXP
pantoprazole results in increased expression of CYP1A1 protein pantoprazole results in decreased expression of CYP1A1 mRNA
CTD
PMID:9152597 PMID:25626140
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression
EXP
pantoprazole results in increased expression of CYP1A2 mRNA; pantoprazole results in increased expression of CYP1A2 protein
CTD
PMID:9152597 PMID:25626140
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
increases expression
EXP
pantoprazole results in increased expression of CYP2B1 protein
CTD
PMID:9152597
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
increases expression
EXP
pantoprazole results in increased expression of CYP2B2 protein
CTD
PMID:9152597
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
affects response to substance increases metabolic processing decreases activity multiple interactions
ISO
CYP2C19 gene polymorphism affects the susceptibility to pantoprazole CYP2C19 protein results in increased metabolism of pantoprazole pantoprazole results in decreased activity of CYP2C19 protein pantoprazole inhibits the reaction [CYP2C19 protein results in increased hydroxylation of Mephenytoin]
CTD
PMID:8930576 PMID:15258107 PMID:20223877 PMID:21795468
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
ISO
Pantoprazole results in increased expression of and results in increased activity of CYP2E1 protein
CTD
PMID:36243147
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases expression increases metabolic processing multiple interactions
ISO
Pantoprazole results in increased expression of CYP3A4 protein CYP3A4 protein results in increased metabolism of Pantoprazole Pantoprazole inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam]
CTD
PMID:8930576 PMID:9744552 PMID:15258107
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Hamp
hepcidin antimicrobial peptide
increases expression
ISO
Pantoprazole results in increased expression of HAMP mRNA
CTD
PMID:31669099
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Jak2
Janus kinase 2
multiple interactions
ISO
pantoprazole decreases expression of JAK2 mRNA and decreases phosphorylation of JAK2 protein in gastrocnemius
RGD
PMID:28489606
RGD:127285673
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
G
Mpo
myeloperoxidase
multiple interactions
EXP
pantoprazole inhibits the reaction [Indomethacin results in increased expression of MPO protein]; pantoprazole inhibits the reaction [Ketoprofen results in increased expression of MPO protein]; pantoprazole inhibits the reaction [Piroxicam results in increased expression of MPO protein]
CTD
PMID:16080005
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Pcna
proliferating cell nuclear antigen
multiple interactions
EXP
[pantoprazole co-treated with Indomethacin] promotes the reaction [Acetic Acid results in increased expression of PCNA protein]; pantoprazole promotes the reaction [Acetic Acid results in increased expression of PCNA protein]
CTD
PMID:18853145
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Retsat
retinol saturase
increases expression
EXP
pantoprazole results in increased expression of RETSAT mRNA
CTD
PMID:25626140
NCBI chr 4:104,653,306...104,662,069
Ensembl chr 4:104,653,155...104,668,310
G
Serping1
serpin family G member 1
decreases expression
EXP
pantoprazole results in decreased expression of SERPING1 mRNA
CTD
PMID:25626140
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
G
Slc22a8
solute carrier family 22 member 8
multiple interactions
ISO
[Pantoprazole results in decreased activity of SLC22A8 protein] which results in decreased uptake of Indican
CTD
PMID:36243147
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
Pantoprazole results in increased expression of TGFB1 protein
CTD
PMID:36243147
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases expression
EXP
pantoprazole results in increased expression of UGT1A1 mRNA
CTD
PMID:25626140
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
increases expression
EXP
pantoprazole results in increased expression of UGT2B1 mRNA
CTD
PMID:25626140
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all